SCHEMBL1367072

SCHEMBL1367072

COc1ccc(/C=C/C(=O)NC(=O)c2cc3cc(Br)ccc3oc2=O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.60
POLB P06746 3/20 0.56
GPR55 Q9Y2T6 1/20 0.56
ALDH1A1 P00352 7/20 0.56
KDM4E B2RXH2 5/20 0.56
HPGD P15428 3/20 0.56
GAA P10253 2/20 0.56
KMT2A Q03164 2/20 0.56
HTT P42858 2/20 0.55
USP2 O75604 1/20 0.55
MAPT P10636 3/20 0.55
MAOB P27338 4/20 0.52
CA12 O43570 2/20 0.51
CA9 Q16790 2/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA3 P07451 1/20 0.51
CA6 P23280 1/20 0.51
CA5A P35218 1/20 0.51
CA7 P43166 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4339721 1.00 MAOA (0.60) MAOAPOLBGPR55ALDH1A1KDM4E
SCHEMBL1367076 1.00 MAOA (0.60) MAOAPOLBGPR55ALDH1A1KDM4E
SCHEMBL1368410 0.88 KMT2A (0.61) POLBALDH1A1KDM4EHPGDGAA
SCHEMBL1368407 0.88 KMT2A (0.61) POLBALDH1A1KDM4EHPGDGAA
SCHEMBL4339669 0.88 KMT2A (0.61) POLBALDH1A1KDM4EHPGDGAA
SCHEMBL1367749 0.86 MAOA (0.76) MAOAPOLBGPR55ALDH1A1KDM4E
SCHEMBL1368322 0.86 MAOA (0.76) MAOAPOLBGPR55ALDH1A1KDM4E
SCHEMBL1367747 0.86 MAOA (0.76) MAOAPOLBGPR55ALDH1A1KDM4E
SCHEMBL1366983 0.86 POLB (0.62) MAOAPOLBGPR55ALDH1A1KDM4E
SCHEMBL1367924 0.86 POLB (0.62) MAOAPOLBGPR55ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US claimed
US-8067461-B2 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-11-29 US disclosed
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof NQO2, NQO1, HCCS MAOA 3570/4885POLB 2722/4885GPR55 4702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.